Search

Displaying results 651 - 660 of 10000 in total
  1. Drug

    Vitamin A

    go.drugbank.com/drugs/DB00162
    ApprovedInvestigationalNutraceuticalVet approved

    Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.

    Synonyms: (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol, Vitamin A AlcoholInternational brands: Chocola A
  2. Drug

    Cefprozil

    go.drugbank.com/drugs/DB01150
    ApprovedInvestigational

    Cefprozil is a cephalosporin antibiotic that is commonly employed to treat a variety of bacterial infections, including those of the ear and skin, bronchitis, and others.

    Categories: Heterocyclic Compounds, 2-RingProducts: CEFPROZIL ORCHID EUROPE, Cefzil Powder for Oral Suspension-250 Mg/ 5 Ml
  3. Drug

    Docusate

    go.drugbank.com/drugs/DB11089
    Approved

    Additionally, it does not appear to lessen symptoms associated with constipation such as abdominal cramps. Still docusate is available in over-the-counter products as a common laxative. … Docusate, or dioctyl sulfosuccinate, is a stool softener indicated for the treatment of constipation[A32201].

    Mixtures: Senna-S, Senexon-SProducts: Doxate-S Cap 100mg USP, Jamp Docusate S Oblong
  4. Drug

    Olea europaea leaf

    go.drugbank.com/drugs/DB14745
    Investigational

    Mixtures: LA FEMME V Feminine CleanserSynonyms: Olea europaea leaf, Olea europaea (olive) leaf
  5. Drug

    Sitagliptin

    go.drugbank.com/drugs/DB01261
    ApprovedInvestigational

    Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus[FDA label,A2260,A2255,A2256

    Mixtures: M-sitagliptin-metformin, M-sitagliptin-metforminCategories: metformin and sitagliptin, Cytochrome P-450 Substrates
  6. Drug

    Ertugliflozin

    go.drugbank.com/drugs/DB11827
    ApprovedInvestigational

    Ertugliflozin is a sodium-dependent glucose cotransporter-2 (SGLT2) inhibitor used to treat type II diabetes mellitus. It works to block glucose reabsorption from the glomerulus. … [A261951, L1132] It was also approved by the European Commission in March 2018.[L48621]

    Mixtures: Segluromet (Ertugliflozin 2.5mg/ Metformin 500mg) Film-Coated Tablet, Segluromet (Ertugliflozin 7.5mg/ Metformin 500mg) Film-Coated TabletCategories: metformin and ertugliflozin, P-glycoprotein substrates
  7. Drug

    Heparin

    go.drugbank.com/drugs/DB01109
    ApprovedInvestigational

    It is a naturally occurring anticoagulant released from mast cells. … UH is different from low molecular weight heparin (LMWH) in the following ways: the average molecular weight of LMWH is about 4.5 kDa whereas it is 15 kDa for UH; UH requires continuous infusions; activated

    Mixtures: /g + 5 mg/g Gel, BARICUS 50 IU/%1/%10 JEL , 50 GProducts: SUMIMED HEPAMAX-S ®, Thrombophob - S Gel
  8. Indication

    Sickle Cell Disease

    go.drugbank.com/conditions/DBCOND0029334
    Drugs: Crizanlizumab · Exagamglogene autotemcel · Hydroxyurea · Lovotibeglogene autotemcel · Piracetam · Voxelotor
    Synonyms: Hemoglobin S-S disease, Haemoglobin S-S disease
  9. Drug

    Nystatin

    go.drugbank.com/drugs/DB00646
    ApprovedInvestigationalVet approved

    [A188562] Nystatin has a greater antifungal activity than amphotericin B - parenterally administered nystatin, however, is associated with significant toxicity and is not available in a formulation appropriate … [L10686] It is one of the most effective antifungal agents synthesized by bacteria, in this case a strain of _Streptomyces noursei_,[L10776] and is closely related to [amphotericin B], differing only slightly

    Mixtures: OLEUM ZINC OX C NYSTAT SR, OLEUM ZINCI OXID C NYST SRCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Pirfenidone

    go.drugbank.com/drugs/DB04951
    ApprovedInvestigational

    Pirfenidone is a synthetic pyridone drug. … [A251370] It is an antifibrotic agent with anti-inflammatory and antioxidant properties [A251370] that is used to treat idiopathic pulmonary fibrosis (IPF),[L26801] which is a chronic, progressive form

    Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesProducts: S, PULPIR® 267